Company profile · Onderzoeks- & kennisinstelling
Epify BV
- Biotechnology
- Onderzoeks- & kennisinstelling
- Maastricht
- Biotechnology · Maastricht
- Employees
- 2–10
- Founded
- 2019
- Province
- Limburg
- Country
- Netherlands
About Epify BV
Epify develops epigenetic biomarkers which control gene activity and are implicated in a wide range of cancers, driving and influencing the development of the disease.
Using these biomarkers, Epify aims to drive earlier detection and more accurate diagnosis, facilitating personalized oncology and better outcomes for cancer patients.
Keywords
- Biomarkers
- Epigenetics
- Oncology
Team by function
Based on 1 public job profiles as of 19 September 2026.
- Other / Unclassifiable1
Similar companies
Companies with a similar profile, Limburg first.
ToxGenSolutions BV TGS
Biotechnology · Maastricht
11–50 employeesView profile
Exomnis Biotech
Biotechnology · Maastricht
2–10 employeesView profile
Temple Therapeutics
Biotechnology · Geleen
2–10 employeesView profile
EnzyPep B.V.
Pharmaceuticals · Geleen
11–50 employeesView profile
Early cancer prediction ECP
Biotechnology · Haarlem
2–10 employeesView profile
Cyclomics
Biotechnology · Amsterdam
11–50 employeesView profile
Looking for more companies like these?
Get a free selection by email, put together by our team.